ENTX

Entera Bio Ltd.

An Israeli biopharmaceutical company turning injections into once-daily pills. Entera Bio develops oral tablets of hormones like parathyroid hormone (PTH), aiming to treat conditions such as osteoporosis and hypoparathyroidism that normally require daily shots, using its proprietary N-Tab platform that helps fragile peptides survive digestion. Founded in 2009 by Phillip Schwartz and Zeev Bronfeld, it reportedly began as a two-person operation in the storage room of an apartment before growing into a NASDAQ-listed company.